Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xingqin Zhou

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
BMC Psychiatry|March 8, 2020
Modulating NMDA receptors to treat MK-801-induced schizophrenic cognition deficit: effects of clozapine combining with PQQ treatment and possible mechanisms of actionXingqin Zhou, Gangming Cai, Shishi Mao, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|July 31, 2021
Clinical Benefit of Therapeutic Drug Monitoring in Colorectal Cancer Patients Who Received Fluorouracil-Based ChemotherapyXingqin Zhou, Yazhou Chang, Jing Qian, et al.
Journal of Radioanalytical and Nuclear Chemistry|July 31, 2015
Preparation of <sup>99m</sup>Tc-PQQ and preliminary biological evaluation for the NMDA receptorYanyan Kong, Xingqin Zhou, Guoxian Cao, et al.
Nuclear Medicine and Biology|April 21, 2012
Preliminary studies of (99m)Tc-memantine derivatives for NMDA receptor imagingXingqin Zhou, Jiankang Zhang, Chenglong Yan, et al.
Die Pharmazie|October 27, 2011
Generation of a liver targeting fusion interferon and its bioactivity analysis in vitroGangming Cai, Mengjun Jiang, Yaoyuan Zhou, et al.
Oncology Letters|June 23, 2020
The effect of TKI therapy and chemotherapy treatment delivery sequence on total progression-free survival in patients with advanced EGFR-mutated NSCLCJie Han, Yan Xu, Yumei Zhou, et al.
Journal of Cellular Physiology|October 5, 2019
Analysis of lncRNA-mRNA networks after MEK1/2 inhibition based on WGCNA in pancreatic ductal adenocarcinomaJing Qian, Jianxin Yang, Xianchen Liu, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
BMC Psychiatry|March 8, 2020
Modulating NMDA receptors to treat MK-801-induced schizophrenic cognition deficit: effects of clozapine combining with PQQ treatment and possible mechanisms of actionXingqin Zhou, Gangming Cai, Shishi Mao, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|July 31, 2021
Clinical Benefit of Therapeutic Drug Monitoring in Colorectal Cancer Patients Who Received Fluorouracil-Based ChemotherapyXingqin Zhou, Yazhou Chang, Jing Qian, et al.
Journal of Radioanalytical and Nuclear Chemistry|July 31, 2015
Preparation of <sup>99m</sup>Tc-PQQ and preliminary biological evaluation for the NMDA receptorYanyan Kong, Xingqin Zhou, Guoxian Cao, et al.
Nuclear Medicine and Biology|April 21, 2012
Preliminary studies of (99m)Tc-memantine derivatives for NMDA receptor imagingXingqin Zhou, Jiankang Zhang, Chenglong Yan, et al.
Die Pharmazie|October 27, 2011
Generation of a liver targeting fusion interferon and its bioactivity analysis in vitroGangming Cai, Mengjun Jiang, Yaoyuan Zhou, et al.
Oncology Letters|June 23, 2020
The effect of TKI therapy and chemotherapy treatment delivery sequence on total progression-free survival in patients with advanced EGFR-mutated NSCLCJie Han, Yan Xu, Yumei Zhou, et al.
Journal of Cellular Physiology|October 5, 2019
Analysis of lncRNA-mRNA networks after MEK1/2 inhibition based on WGCNA in pancreatic ductal adenocarcinomaJing Qian, Jianxin Yang, Xianchen Liu, et al.
Pageof 2